Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Novel gene explains fatal ARDS in Dalmatians
dalmatian
Breeders have learned to avoid the risk lines but it is challenging to eradicate recessive disorders such as ARDS without genetic testing, as the carriers are not affected by the disease.
Discovery could help to diagnose and treat the syndrome

Scientists have discovered a novel gene associated with acute respiratory distress syndrome (ARDS) in Dalmatians. The research could help to diagnose and eradicate the disease in dogs, as well as improving understanding of respiratory disease in humans.

ARDS has an early onset, with puppies and young dogs experiencing difficulty breathing, leading to rapid death. It has been known to affect the breed for some time, although the frequency of carriers is said to be low. Breeders have learned to avoid the risk lines but it is challenging to eradicate recessive disorders such as ARDS without genetic testing, as the carriers are not affected by the disease.

Professor Hannes Lohi from the University of Helsinki explained to Science Daily: “There are many causes for lethal acute respiratory distress. In humans, the underlying cause is often pneumonia, inflammation or pulmonary fibrosis.

“In Dalmatians, the cause is a genetic lung tissue disorder. Our study indicates that the disorder results from a defect in an anilin protein which binds to actin, the supporting microfilaments in the cell.”

Anilin is important for cell division and growth. According to Dr Marjo Hytönen, the lung injury in affected dogs appears to be linked to an abnormal regeneration capacity of the bronchiolar epithelium. “The ANLN gene discovery is in line with this manifestation of the disease,” Dr Hytönen explained.

Researchers examined material previously collected at the university’s Veterinary Teaching Hospital, as well as canine biobank samples. They tested 180 Dalmatians and 30 pointers for the mutation association with ARDS, finding less than two per cent of the Dalmatians had it, while none of the pointers did.

Some of the affected dogs only had one kidney, while others had hydrocephalus, which suggests ANLN has “broader significance for the development of the epithelium in different organs,” Dr Hytönen added.

Veterinary pathologist Pernilla Syrjä said: “This gene discovery provides new insights into the mechanisms of lung injuries. Typically, lung injuries in the affected Dalmatians are associated with disorders in the cellular regeneration and intercellular junctions.

“The lack of anillin, the actin-binding protein, can perfectly explain the changes which we see on the cellular level. Due to the malformed epithelial structure, inhaled air is trapped in the alveolar level, over-extending the alveolar walls.”

The genetic test will be made available via the MyDogDNA test, www.mydogdna.com

The findings have been published in the journal PLOS Genetics

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.